At ASCO 2012, it was shown that Gemcitabine might not improve the prognosis of the HER2-negative and lymph node positive breast cancer patients.For the adjuvant chemotherapy to the HER2-negative and lymph node positive breast cancer patien…

Now we can use several adjuvant chemotherapy for the breast cancer treatment after surgery, but it is not clear which is the best. Because each patient have different background and the breast cancer is classified to several subtype, to ha…